Members of Congress Amicus Brief in Alliance for Hippocratic Medicine v. FDA

This brief was filed on behalf of 253 members of Congress who emphasize approval of mifepristone and other challenged agency actions has no basis in law, threatens the Congressionally mandated drug approval process, and poses a serious health risk to pregnant individuals by making abortion more difficult to access—when access has already been seriously eroded in the aftermath of Dobbs v. Jackson Women’s Health Organization. The brief emphasizes that Congress charged experts at FDA with evaluating the safety and efficacy of drugs, that FDA’s determination that mifepristone is safe and effective followed a thorough and comprehensive process prescribed and overseen by the legislative branch, and that invalidating FDA’s approval would reduce access to abortion, exacerbating an already significant reproductive health process.

This brief was one of many filed in Alliance for Hippocratic Medicine v. FDA. For more information on the case, click here.